Ads
related to: fda- Contact Us
Call + Email
24/7 Live Chat
- FDA Registration
Quick & Easy
Register Your Business
- Verify: FDA Registration
Free Tool To Verify That Your US
FDA Registration Is Currently Valid
- Food & Beverage
Full Service
Everything You Need
- Contact Us
Search results
ImmunityBio stock jumps as FDA clears bladder cancer therapy (NASDAQ:IBRX)
Seeking Alpha· 2 hours agoShares of ImmunityBio (IBRX) surged 33% premarket after FDA clearance of its combination therapy for...
Medivir provides update from supportive Type C meeting with the FDA; preparations for enhanced phase...
FOX 23 News Albany· 4 hours agoMedivir AB (NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative...
FDA approves bladder cancer treatment by Culver City company
Los Angeles Times· 7 hours agoThe treatment, which will be sold under the brand name Anktiva, is intended for some patients...
FDA Chief Says CBD Is Not NBD, Urges Congressional Action
The National Law Review· 19 hours agoSupporters of hemp-derived cannabidiol (CBD) who hoped the Food and Drug Administration would adopt...
Here’s Why Merck & Co. (MRK) Outperformed in Q1
Insider Monkey via Yahoo Finance· 5 minutes agoBaron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be...
FDA requests more info for Abeona pz-cel market application (NASDAQ:ABEO)
Seeking Alpha· 15 hours agoThe FDA has declined to approve Abeona Therapeutics' (ABEO) therapy pz-cel, stating that it needs...
FDA grants breakthrough status for Kura Oncology's AML drug candicate By Investing.com
Investing.com· 24 hours agoKura Oncology, Inc. (NASDAQ:KURA), a clinical-stage biopharmaceutical company, has announced that...
US FDA approves ImmunityBio's bladder cancer therapy
Reuters via Yahoo News· 13 hours ago(Reuters) -The U.S. health regulator approved on Monday ImmunityBio's combination therapy to treat a type of bladder cancer, marking an end to the...
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
InvestorPlace· 6 days agoIn the biotech and pharmaceutical world, FDA approval is the number one needle mover for drug...
ImmunityBio Shares Soar Premarket on FDA Nod for Anktiva
Morningstar· 1 hour agoBy Colin Kellaher Shares of ImmunityBio jumped more than 25% in premarket trading Tuesday after the immunotherapy company received Food and Drug Administration approval of its Anktiva treatment for certain patients with bladder cancer. ImmunityBio
Ad
related to: fda